Teladoc Inc (NYSE:TDOC) – Investment analysts at William Blair issued their Q1 2019 earnings estimates for Teladoc in a research note issued on Monday. William Blair analyst R. Daniels anticipates that the health services provider will post earnings per share of ($0.23) for the quarter. William Blair also issued estimates for Teladoc’s Q2 2019 earnings at ($0.18) EPS, Q3 2019 earnings at ($0.18) EPS and Q4 2019 earnings at ($0.22) EPS.
Teladoc (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, November 1st. The health services provider reported ($0.55) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.25). The company had revenue of $68.70 million during the quarter, compared to the consensus estimate of $67.53 million. Teladoc had a negative net margin of 45.64% and a negative return on equity of 29.70%. Teladoc’s quarterly revenue was up 112.0% on a year-over-year basis. During the same period in the prior year, the company posted ($0.33) EPS.
Teladoc (NYSE:TDOC) traded down $0.55 during midday trading on Thursday, hitting $32.65. The company’s stock had a trading volume of 1,910,000 shares, compared to its average volume of 1,190,000. The company has a market capitalization of $1,980.00 and a PE ratio of -22.52. Teladoc has a 52 week low of $15.65 and a 52 week high of $38.40. The company has a debt-to-equity ratio of 0.83, a current ratio of 5.08 and a quick ratio of 5.08.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Raymond James Trust N.A. grew its position in Teladoc by 36.2% during the 3rd quarter. Raymond James Trust N.A. now owns 9,943 shares of the health services provider’s stock worth $330,000 after purchasing an additional 2,643 shares in the last quarter. American International Group Inc. grew its position in Teladoc by 8.1% during the 3rd quarter. American International Group Inc. now owns 36,079 shares of the health services provider’s stock worth $1,196,000 after purchasing an additional 2,697 shares in the last quarter. Swiss National Bank grew its position in Teladoc by 4.8% during the 2nd quarter. Swiss National Bank now owns 59,500 shares of the health services provider’s stock worth $2,065,000 after purchasing an additional 2,700 shares in the last quarter. Ameritas Investment Partners Inc. grew its position in Teladoc by 134.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,724 shares of the health services provider’s stock worth $164,000 after purchasing an additional 2,707 shares in the last quarter. Finally, Brown Advisory Inc. grew its position in Teladoc by 38.3% during the 3rd quarter. Brown Advisory Inc. now owns 10,521 shares of the health services provider’s stock worth $348,000 after purchasing an additional 2,915 shares in the last quarter.
In other Teladoc news, VP Mark Hirschhorn sold 35,000 shares of Teladoc stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $32.84, for a total transaction of $1,149,400.00. Following the transaction, the vice president now directly owns 20,887 shares in the company, valued at approximately $685,929.08. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jason N. Gorevic sold 100,000 shares of Teladoc stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $32.99, for a total transaction of $3,299,000.00. Following the transaction, the chief executive officer now owns 718,261 shares in the company, valued at $23,695,430.39. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 210,000 shares of company stock worth $6,889,350. Corporate insiders own 4.47% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Teladoc Inc (TDOC) Forecasted to Earn Q1 2019 Earnings of ($0.23) Per Share” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3136548/teladoc-inc-tdoc-forecasted-to-earn-q1-2019-earnings-of-0-23-per-share.html.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.